Skip to main content
Equibles

5187 · CREATE MEDIC CO.,LTD. · Financials

Use 5187 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 5187.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,094 JPY +6 (+0.55%) At close · Nov 12
Rebalance outlook locked
Market Cap
8.71B JPY
Shares
7.96M
Volume · Nov 12 3500 Avg daily vol (3M) 4620

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
13.62B +4.5%
FY2025 Revenue FY2021–FY2025
Net Income
713.73M -15.1%
FY2025 Net Income FY2021–FY2025
Gross Margin
44.02% +0.2pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
7.38% +2.1pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
530.12M -76.4%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 13.62B 13.03B 12.59B 12.26B 11.7B
JPY 7.62B 7.33B 7.11B 6.88B 6.44B
JPY 5.99B 5.7B 5.48B 5.37B 5.26B
JPY 1.01B 692.46M 803.24M 737.71M 866.78M
JPY 1.06B 1.09B 904.02M 836.74M 965.63M
JPY 347.01M 245.93M 750M 376.1M 305.22M
JPY 713.73M 840.9M 154.02M 460.65M 660.41M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 1.67B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.